MNDR
Mobile-health·NASDAQ
--
--(--)
--
--(--)
1.26 / 10
Underperform
Fundamentals are underperforming, scoring 1.3/10. Inventory turnover days and return on assets are negative, ROE is -129%, indicating severe profitability issues and bearish outlook.
Analysis Checks(0/4)
Rate of return on total assets (%)
Value-10.79
Score1/3
Weight15.19%
1M Return-0.38%
Value-10.79
Score1/3
Weight15.19%
1M Return-0.38%
ROE (diluted) (%)
Value-129.31
Score0/3
Weight67.65%
1M Return-1.78%
Value-129.31
Score0/3
Weight67.65%
1M Return-1.78%
Annualized return on total assets (%)
Value-10.79
Score1/3
Weight15.19%
1M Return-0.38%
Value-10.79
Score1/3
Weight15.19%
1M Return-0.38%
Inventory turnover days
Value7.57
Score1/3
Weight1.97%
1M Return-0.05%
Value7.57
Score1/3
Weight1.97%
1M Return-0.05%
Rate of return on total assets (%)
Value-10.79
Score1/3
Weight15.19%
1M Return-0.38%
Value-10.79
Score1/3
Weight15.19%
1M Return-0.38%
Annualized return on total assets (%)
Value-10.79
Score1/3
Weight15.19%
1M Return-0.38%
Value-10.79
Score1/3
Weight15.19%
1M Return-0.38%
ROE (diluted) (%)
Value-129.31
Score0/3
Weight67.65%
1M Return-1.78%
Value-129.31
Score0/3
Weight67.65%
1M Return-1.78%
Inventory turnover days
Value7.57
Score1/3
Weight1.97%
1M Return-0.05%
Value7.57
Score1/3
Weight1.97%
1M Return-0.05%
Is MNDR undervalued or overvalued?
- MNDR scores 1.26/10 on fundamentals and holds a Premium valuation at present. Backed by its -15.69% ROE, -35.33% net margin, -1.63 P/E ratio, 0.51 P/B ratio, and 86.43% earnings growth, these metrics solidify its Underperform investment rating.
